United States · FDA National Drug Code directory
Ondansetron
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55154-8339_536561ac-f104-46f2-abe4-bfb59793ed61
- Product NDC
- 55154-8339
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Ondansetron
- Labeler
- Cardinal Health 107, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241031
- Source listing expiry
- 20261231
Source-listed ingredients
- ONDANSETRON — 8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BLISTER PACK in 1 CARTON (55154-8339-0) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 55154-8339-0
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →